"Metabolite","Coef_RA_HC","PValue_RA_HC","CI_Lower_RA_HC","CI_Upper_RA_HC","Coef_RA_atRisk","PValue_RA_atRisk","CI_Lower_RA_atRisk","CI_Upper_RA_atRisk","Coef_HC_atRisk","PValue_HC_atRisk","CI_Lower_HC_atRisk","CI_Upper_HC_atRisk","RA_HC.color_ra","PRA_HC.color_ra","RA_PRA.color_ra"
"2-Aminoadipic 2-Oxoadipic Aciduria",-0.620343502867699,2.82758844017656e-41,-0.697855076764188,-0.54283192897121,-0.384908418208681,1.23047741421851e-11,-0.49176044131948,-0.278056395097881,0.232042808191472,8.6964418393775e-07,0.142705899784322,0.321379716598622,"negative","negative","negative"
"2-Hydroxyglutric Aciduria ",-0.374420687122854,8.02888392384289e-33,-0.429040812509613,-0.319800561736095,-0.0767070351514197,0.0495769072255869,-0.153271119420699,-0.000142950882140308,0.316029086275747,3.35861762249219e-15,0.244885475141182,0.387172697410312,"negative","negative","no"
"2-Ketoglutarate Dehydrogenase Complex Deficiency",-0.180772782799269,4.03200419098862e-06,-0.256532331476725,-0.105013234121814,-0.0784569223215231,0.112804422418315,-0.175554585287608,0.018640740644562,0.103985623474905,0.0489016635272654,0.000507182032320322,0.207464064917491,"negative","no","no"
"2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"27-Hydroxylase Deficiency",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Hydroxyisobutyric Acid Dehydrogenase Deficiency",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Hydroxyisobutyric Aciduria",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Methylcrotonyl-CoA Carboxylase Deficiency Type I",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Methylglutaconic Aciduria Type I",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Methylglutaconic Aciduria Type III",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Methylglutaconic Aciduria Type IV",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"3-Methylthiofentanyl Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"3-Phosphoglycerate Dehydrogenase Deficiency",-0.268858752062275,1.55604190596487e-19,-0.32344167948569,-0.214275824638859,-0.085160054872912,0.0229699461040202,-0.158467937938359,-0.0118521718074652,0.174954878047603,2.10183473383534e-06,0.104900070575799,0.245009685519407,"negative","negative","no"
"4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency",-0.374420687122854,8.02888392384289e-33,-0.429040812509613,-0.319800561736095,-0.0767070351514197,0.0495769072255869,-0.153271119420699,-0.000142950882140308,0.316029086275747,3.35861762249219e-15,0.244885475141182,0.387172697410312,"negative","negative","no"
"5-Oxoprolinase Deficiency",-0.35609441491958,5.80996653422029e-14,-0.444998242629957,-0.267190587209203,-0.204845032811655,0.00119796930017689,-0.327993667756627,-0.0816963978666841,0.183476018986936,0.00105868950567091,0.0749113421461793,0.292040695827692,"negative","negative","negative"
"5-Oxoprolinuria",-0.35609441491958,5.80996653422029e-14,-0.444998242629957,-0.267190587209203,-0.204845032811655,0.00119796930017689,-0.327993667756627,-0.0816963978666841,0.183476018986936,0.00105868950567091,0.0749113421461793,0.292040695827692,"negative","negative","negative"
"Acetaminophen  Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Acetaminophen Metabolism Pathway",-0.399531611738818,1.32688792749574e-11,-0.511291827875957,-0.287771395601679,-0.310283797265985,3.94231502826206e-05,-0.456367130570406,-0.164200463961563,0.096745781321404,0.242881006515681,-0.0662953909353137,0.259786953578122,"negative","no","negative"
"Acetylsalicylic Acid Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Acute Intermittent Porphyria",-0.657579932032959,2.62706059132273e-42,-0.738345748720594,-0.576814115345324,-0.291476592541191,8.99235998223182e-07,-0.405506689731086,-0.177446495351295,0.355711490769724,1.36469168874233e-08,0.238684081443949,0.472738900095498,"negative","negative","negative"
"Adenine Phosphoribosyltransferase Deficiency ",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Adenosine Deaminase Deficiency",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Adenylosuccinate Lyase Deficiency",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Adrenoleukodystrophy, X-Linked",0.0527853874591241,0.306877513481269,-0.0486990504535629,0.154269825371811,-0.154164239357152,0.026893690533995,-0.29055902831255,-0.0177694504017552,-0.194635838952617,0.00961792983757362,-0.341263923104173,-0.0480077548010623,"no","positive","no"
"AICA-Ribosiduria",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Alanine Metabolism",-0.0980723140418954,0.00173968572410471,-0.159154337092555,-0.036990290991236,0.087287565902616,0.0439717484139801,0.00237478244419473,0.172200349361037,0.185378035881885,3.71066709752225e-06,0.109140744930435,0.261615326833334,"negative","negative","no"
"Alendronate Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Alfentanil Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Alkaptonuria",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"Alvimopan Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Amikacin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Amino Sugar Metabolism",-0.109541315031701,0.00301671408032004,-0.181630811862178,-0.0374518182012248,-0.0732199142792971,0.105603158952855,-0.162004019164986,0.0155641906063914,0.0391412968831269,0.487434028051727,-0.0719561529470854,0.150238746713339,"negative","no","no"
"Ammonia Recycling",-0.598331987718968,1.29703843597097e-63,-0.652666426254037,-0.543997549183899,-0.329228413501258,7.80778928354142e-15,-0.407796481712968,-0.250660345289549,0.276224755191231,2.05129822760154e-13,0.20858371430748,0.343865796074981,"negative","negative","negative"
"Anileridine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Antipyrine Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Antrafenine Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Arachidonic Acid Metabolism",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Arbekacin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Arginine and Proline Metabolism",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Arginine: Glycine Amidinotransferase Deficiency ",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Argininemia",-0.316417379674907,2.90531115557552e-26,-0.369755893553278,-0.263078865796536,-0.0583177485425949,0.141909714864677,-0.136267370240607,0.0196318731554168,0.264280168738924,1.22602393536328e-13,0.200276295732321,0.328284041745527,"negative","negative","no"
"Argininosuccinic Aciduria",-0.316417379674907,2.90531115557552e-26,-0.369755893553278,-0.263078865796536,-0.0583177485425949,0.141909714864677,-0.136267370240607,0.0196318731554168,0.264280168738924,1.22602393536328e-13,0.200276295732321,0.328284041745527,"negative","negative","no"
"Aromatic L-Aminoacid Decarboxylase Deficiency",-0.313260932996422,1.28668602260984e-11,-0.400826730536599,-0.225695135456245,-0.201137375430878,0.000991510873093534,-0.320050019381108,-0.082224731480647,0.144884943754593,0.00379831091903905,0.0475175812835581,0.242252306225627,"negative","negative","negative"
"Aspartate Metabolism",-0.247268583164232,5.74933323208967e-18,-0.300135099262824,-0.19440206706564,-0.238710901568552,1.17575890044112e-09,-0.313178268512804,-0.164243534624299,0.0170482816131327,0.625442979441999,-0.0518135270945629,0.0859100903208282,"negative","no","negative"
"Atorvastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Azathioprine Action Pathway",-0.234077698349451,3.99487673551835e-15,-0.289718307010266,-0.178437089688636,0.0472018199643012,0.21569378762083,-0.0276890174055213,0.122092657334124,0.295154473770948,1.35902735494952e-12,0.219765105179077,0.370543842362818,"negative","negative","no"
"Azithromycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Benzocaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"beta-Alanine Metabolism",-0.489188893230055,6.79047445290677e-37,-0.555189121086438,-0.423188665373672,-0.187178654061121,5.19235779123498e-05,-0.276743301827668,-0.0976140062945739,0.324762160263937,5.28800235203647e-10,0.228140186298039,0.421384134229835,"negative","negative","negative"
"beta-Ketothiolase Deficiency",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"beta-Mercaptolactate-Cysteine Disulfiduria",-0.648183228456036,1.15093298343467e-41,-0.728646103539098,-0.567720353372974,-0.15188201728572,0.00998834274506333,-0.267121343649892,-0.0366426909215489,0.509237825472755,1.27493996582857e-16,0.40137228546597,0.61710336547954,"negative","negative","negative"
"beta-Ureidopropionase Deficiency",-0.201664344141794,6.41701068234481e-09,-0.268076385489351,-0.135252302794238,-0.238361677290802,4.67245188355955e-08,-0.321743906122532,-0.154979448459072,-0.0443083534282575,0.39930874938211,-0.147880580722982,0.0592638738664673,"negative","no","negative"
"Beta Oxidation of Very Long Chain Fatty Acids",0.0527853874591241,0.306877513481269,-0.0486990504535629,0.154269825371811,-0.154164239357152,0.026893690533995,-0.29055902831255,-0.0177694504017552,-0.194635838952617,0.00961792983757362,-0.341263923104173,-0.0480077548010623,"no","positive","no"
"Betaine Metabolism",-0.189852975002951,2.35433476804233e-07,-0.260487084943801,-0.1192188650621,-0.0658765860728701,0.159986658830116,-0.157931345629916,0.026178173484176,0.124372625225663,0.0127872621343638,0.026845004038744,0.221900246412582,"negative","no","no"
"Bile Acid Biosynthesis",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"Biotin Metabolism",-0.0535768514206945,0.231184741839705,-0.141454846261855,0.0343011434204661,-0.331819512852461,3.19199252352411e-07,-0.456329870415348,-0.207309155289573,-0.257811677355895,6.52318225007046e-05,-0.381812740817065,-0.133810613894725,"no","positive","negative"
"Biotinidase Deficiency",-0.0535768514206945,0.231184741839705,-0.141454846261855,0.0343011434204661,-0.331819512852461,3.19199252352411e-07,-0.456329870415348,-0.207309155289573,-0.257811677355895,6.52318225007046e-05,-0.381812740817065,-0.133810613894725,"no","positive","negative"
"Bromfenac Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Bupivacaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Buprenorphine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Butyrate Metabolism",-0.190224020134609,0.000207600906978487,-0.289907596198999,-0.0905404440702197,-0.125638732179093,0.0616828746879176,-0.257467062517657,0.00618959815947198,0.0553197800423701,0.440349447899349,-0.0859602248311991,0.196599784915939,"negative","no","no"
"Canavan Disease",-0.247268583164232,5.74933323208967e-18,-0.300135099262824,-0.19440206706564,-0.238710901568552,1.17575890044112e-09,-0.313178268512804,-0.164243534624299,0.0170482816131327,0.625442979441999,-0.0518135270945629,0.0859100903208282,"negative","no","negative"
"Carbamoyl Phosphate Synthetase Deficiency",-0.316417379674907,2.90531115557552e-26,-0.369755893553278,-0.263078865796536,-0.0583177485425949,0.141909714864677,-0.136267370240607,0.0196318731554168,0.264280168738924,1.22602393536328e-13,0.200276295732321,0.328284041745527,"negative","negative","no"
"Cardiolipin Biosynthesis",-0.0944297151419836,0.0685530254737735,-0.196089729077557,0.00723029879358973,0.0230330898499573,0.734522513690824,-0.110567048647698,0.156633228347612,0.119690380756459,0.101803004747446,-0.0239644387896251,0.263345200302542,"no","no","no"
"Cardiolipin Biosynthesis ",-0.0944297151419836,0.0685530254737735,-0.196089729077557,0.00723029879358973,0.0230330898499573,0.734522513690824,-0.110567048647698,0.156633228347612,0.119690380756459,0.101803004747446,-0.0239644387896251,0.263345200302542,"no","no","no"
"Cardiolipin Biosynthesis CL",-0.0944297151419836,0.0685530254737735,-0.196089729077557,0.00723029879358973,0.0230330898499573,0.734522513690824,-0.110567048647698,0.156633228347612,0.119690380756459,0.101803004747446,-0.0239644387896251,0.263345200302542,"no","no","no"
"Carfentanil Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Carnitine-Acylcarnitine Translocase Deficiency",0.0527853874591241,0.306877513481269,-0.0486990504535629,0.154269825371811,-0.154164239357152,0.026893690533995,-0.29055902831255,-0.0177694504017552,-0.194635838952617,0.00961792983757362,-0.341263923104173,-0.0480077548010623,"no","positive","no"
"Carnitine Palmitoyl Transferase Deficiency I",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Carnitine Palmitoyl Transferase Deficiency II",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Carnitine Synthesis",-0.366853331813023,1.52641794707266e-27,-0.426839189845306,-0.30686747378074,-0.335286029625502,3.18388213911506e-15,-0.414015910934638,-0.256556148316366,0.0510402393393733,0.156943917111576,-0.019852776286334,0.121933254965081,"negative","no","negative"
"Carnosinuria, Carnosinemia",-0.489188893230055,6.79047445290677e-37,-0.555189121086438,-0.423188665373672,-0.187178654061121,5.19235779123498e-05,-0.276743301827668,-0.0976140062945739,0.324762160263937,5.28800235203647e-10,0.228140186298039,0.421384134229835,"negative","negative","negative"
"Carprofen Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Catecholamine Biosynthesis",-0.313260932996422,1.28668602260984e-11,-0.400826730536599,-0.225695135456245,-0.201137375430878,0.000991510873093534,-0.320050019381108,-0.082224731480647,0.144884943754593,0.00379831091903905,0.0475175812835581,0.242252306225627,"negative","negative","negative"
"Celecoxib Action Pathway",0.169298568163877,0.00026966586369893,0.0789178908378665,0.259679245489888,-0.0640092696721599,0.299265047647574,-0.185192507108407,0.0571739677640876,-0.221753771454006,0.000214174801240175,-0.337242919654099,-0.106264623253914,"positive","positive","no"
"Cerebrotendinous Xanthomatosis ",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"Cerivastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"CHILD Syndrome",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Chloramphenicol Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Chloroprocaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Cholesteryl Ester Storage Disease",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Chondrodysplasia Punctata II, X-Linked Dominant ",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Citalopram Action Pathway",-0.289418481004223,5.72127366110328e-07,-0.400884260933194,-0.177952701075252,-0.212279144544385,0.00538940327791996,-0.361230111825127,-0.0633281772636427,0.0773833403283189,0.324320925163205,-0.077235373091814,0.232002053748452,"negative","no","negative"
"Citric Acid Cycle",-0.180772782799269,4.03200419098862e-06,-0.256532331476725,-0.105013234121814,-0.0784569223215231,0.112804422418315,-0.175554585287608,0.018640740644562,0.103985623474905,0.0489016635272654,0.000507182032320322,0.207464064917491,"negative","no","no"
"Citrullinemia Type I",-0.316417379674907,2.90531115557552e-26,-0.369755893553278,-0.263078865796536,-0.0583177485425949,0.141909714864677,-0.136267370240607,0.0196318731554168,0.264280168738924,1.22602393536328e-13,0.200276295732321,0.328284041745527,"negative","negative","no"
"Clarithromycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Clindamycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Clomocycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Cocaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Codeine Action Pathway",-0.242191712537503,1.3014365117396e-05,-0.349708479722094,-0.134674945352912,-0.222325630211154,0.00235924592301492,-0.364880980588343,-0.0797702798339648,0.0143651283907423,0.85383460628306,-0.139433746074371,0.168164002855856,"negative","no","negative"
"Congenital Bile Acid Synthesis Defect Type II",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"Congenital Bile Acid Synthesis Defect Type III",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"Congenital Disorder of Glycosylation CDG-IId",0.305072512881674,3.20200612901307e-09,0.206675686446889,0.403469339316459,-0.25634786514632,0.000129084429569322,-0.386230510295521,-0.126465219997119,-0.543146813106181,1.09353104647186e-11,-0.688932564915826,-0.397361061296537,"positive","positive","negative"
"Congenital Erythropoietic Porphyria ",-0.657579932032959,2.62706059132273e-42,-0.738345748720594,-0.576814115345324,-0.291476592541191,8.99235998223182e-07,-0.405506689731086,-0.177446495351295,0.355711490769724,1.36469168874233e-08,0.238684081443949,0.472738900095498,"negative","negative","negative"
"Congenital Lactic Acidosis",-0.180772782799269,4.03200419098862e-06,-0.256532331476725,-0.105013234121814,-0.0784569223215231,0.112804422418315,-0.175554585287608,0.018640740644562,0.103985623474905,0.0489016635272654,0.000507182032320322,0.207464064917491,"negative","no","no"
"Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Cystathionine beta-Synthase Deficiency",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Cysteine Metabolism",-0.648183228456036,1.15093298343467e-41,-0.728646103539098,-0.567720353372974,-0.15188201728572,0.00998834274506333,-0.267121343649892,-0.0366426909215489,0.509237825472755,1.27493996582857e-16,0.40137228546597,0.61710336547954,"negative","negative","negative"
"Cystinosis, Ocular Nonnephropathic",-0.648183228456036,1.15093298343467e-41,-0.728646103539098,-0.567720353372974,-0.15188201728572,0.00998834274506333,-0.267121343649892,-0.0366426909215489,0.509237825472755,1.27493996582857e-16,0.40137228546597,0.61710336547954,"negative","negative","negative"
"D-Glyceric Acidura",-0.00475568715682979,0.916974770080633,-0.0944524454917242,0.0849410711780646,-0.0872859734311423,0.153030025775695,-0.207219014568239,0.0326470677059548,-0.0540044753863623,0.413587916916845,-0.184150997329432,0.0761420465567075,"no","no","no"
"De Novo Triacylglycerol Biosynthesis",-0.165096592653815,0.00252741808549961,-0.271775568670432,-0.0584176166371972,0.0286559188732661,0.690217336037825,-0.112762150740097,0.17007398848663,0.207556319671286,0.00665815830772987,0.0585161062557698,0.356596533086803,"negative","negative","no"
"De Novo Triacylglycerol Biosynthesis TG",-0.165096592653815,0.00252741808549961,-0.271775568670432,-0.0584176166371972,0.0286559188732661,0.690217336037825,-0.112762150740097,0.17007398848663,0.207556319671286,0.00665815830772987,0.0585161062557698,0.356596533086803,"negative","negative","no"
"Demeclocycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Desipramine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Desmosterolosis",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Dezocine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Dibucaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Diclofenac Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Diflunisal Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Dihydromorphine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Dihydropyrimidinase Deficiency",-0.201664344141794,6.41701068234481e-09,-0.268076385489351,-0.135252302794238,-0.238361677290802,4.67245188355955e-08,-0.321743906122532,-0.154979448459072,-0.0443083534282575,0.39930874938211,-0.147880580722982,0.0592638738664673,"negative","no","negative"
"Dihydropyrimidine Dehydrogenase Deficiency ",-0.268858752062275,1.55604190596487e-19,-0.32344167948569,-0.214275824638859,-0.085160054872912,0.0229699461040202,-0.158467937938359,-0.0118521718074652,0.174954878047603,2.10183473383534e-06,0.104900070575799,0.245009685519407,"negative","negative","no"
"Dimethylglycine Dehydrogenase Deficiency",-0.059936155053689,5.37609373285108e-11,-0.0772672947386888,-0.0426050153686892,-0.0152421992275779,0.190213718798996,-0.0380944576061197,0.00761005915096382,0.0412865911671709,0.000264565156980906,0.0194519774357709,0.063121204898571,"negative","negative","no"
"Dimethylthiambutene Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Diphenoxylate Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Disulfiram Action Pathway",-0.264572906615375,8.14545101145043e-14,-0.33105686365153,-0.19808894957922,-0.119640893118209,0.0085372449427528,-0.208536011600372,-0.0307457746360454,0.157822108304568,4.62185560550572e-05,0.0835035499000982,0.232140666709038,"negative","negative","negative"
"Dopamine Activation of Neurological Reward System",-0.141034808252332,0.0217441673972772,-0.261349143656054,-0.0207204728486099,-0.242484134574989,0.00222611894068038,-0.397062295559862,-0.0879059735901155,-0.0942680117235134,0.286648600763534,-0.268454522332616,0.0799184988855888,"no","no","negative"
"Dopamine beta-Hydroxylase Deficiency",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"Doxycycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Erythromycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Escitalopram Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Estrone Metabolism",-0.711315894096129,2.09536352580469e-45,-0.794443415842211,-0.628188372350047,-0.497924733914213,2.49652784448952e-15,-0.614340904632941,-0.381508563195486,0.216558673909557,0.000197550009053811,0.104423377109016,0.328693970710098,"negative","negative","negative"
"Ethanol Degradation",-0.417433685688119,2.03599691146647e-12,-0.529431007344168,-0.30543636403207,-0.149244911376291,0.0560442016251673,-0.302366575655754,0.00387675290317172,0.25473015865044,0.00257979135734199,0.090518280516366,0.418942036784514,"negative","negative","no"
"Ethylmalonic Encephalopathy",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Ethylmorphine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Etodolac Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Etoposide Action Pathway",-0.37795968499118,1.08468358297341e-10,-0.48916504783422,-0.26675432214814,-0.377739376166937,7.84300451713364e-07,-0.524679143144411,-0.230799609189463,-0.0118277077903479,0.891629359839273,-0.183064639415899,0.159409223835203,"negative","no","negative"
"Etoposide Metabolism Pathway",-0.37795968499118,1.08468358297341e-10,-0.48916504783422,-0.26675432214814,-0.377739376166937,7.84300451713364e-07,-0.524679143144411,-0.230799609189463,-0.0118277077903479,0.891629359839273,-0.183064639415899,0.159409223835203,"negative","no","negative"
"Etoricoxib Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Excitatory Neural Signalling Through 5-HTR 4 and Serotonin",-0.00279050648696075,0.959064692620336,-0.109685370416647,0.104104357442725,-0.29706606984093,0.000102096703307427,-0.445293950614356,-0.148838189067503,-0.311509926882126,0.000669953901376196,-0.488691184380836,-0.134328669383416,"no","positive","negative"
"Excitatory Neural Signalling Through 5-HTR 6 and Serotonin",-0.00279050648696075,0.959064692620336,-0.109685370416647,0.104104357442725,-0.29706606984093,0.000102096703307427,-0.445293950614356,-0.148838189067503,-0.311509926882126,0.000669953901376196,-0.488691184380836,-0.134328669383416,"no","positive","negative"
"Excitatory Neural Signalling Through 5-HTR 7 and Serotonin",-0.00279050648696075,0.959064692620336,-0.109685370416647,0.104104357442725,-0.29706606984093,0.000102096703307427,-0.445293950614356,-0.148838189067503,-0.311509926882126,0.000669953901376196,-0.488691184380836,-0.134328669383416,"no","positive","negative"
"Fabry Disease",0.116922901945543,0.0317547904360174,0.0102776092821764,0.22356819460891,-0.271607706826322,0.00024487512935041,-0.415416967218206,-0.127798446434438,-0.397932524248507,7.6463545094452e-07,-0.550294121354985,-0.245570927142029,"no","positive","negative"
"Familial Hypercholanemia ",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"Familial Lipoprotein Lipase Deficiency",-0.00475568715682979,0.916974770080633,-0.0944524454917242,0.0849410711780646,-0.0872859734311423,0.153030025775695,-0.207219014568239,0.0326470677059548,-0.0540044753863623,0.413587916916845,-0.184150997329432,0.0761420465567075,"no","no","no"
"Fanconi-Bickel Syndrome",-0.315212581075567,3.84684980215976e-12,-0.400962233135364,-0.229462929015769,-0.148842810706486,0.00917591483915739,-0.260494334232225,-0.0371912871807475,0.182282779930143,0.00388361326610506,0.0594784407969867,0.305087119063299,"negative","negative","negative"
"Fatty Acid Biosynthesis",0.158134659842569,0.00920877275916619,0.0394087902864896,0.276860529398648,0.169595354535471,0.0325938731985602,0.0141620343914714,0.32502867467947,-0.0190746110519624,0.817681176148222,-0.182273276765567,0.144124054661643,"positive","no","no"
"Fatty Acid Metabolism",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Fenoprofen Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Fentanyl Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Fluoxetine Action Pathway",-0.289418481004223,5.72127366110328e-07,-0.400884260933194,-0.177952701075252,-0.212279144544385,0.00538940327791996,-0.361230111825127,-0.0633281772636427,0.0773833403283189,0.324320925163205,-0.077235373091814,0.232002053748452,"negative","no","negative"
"Flurbiprofen Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Fluvastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Folate Malabsorption, Hereditary",-0.189719059046163,0.000637256380732992,-0.297894386520203,-0.0815437315721217,-0.123961687438402,0.0944385273083923,-0.269381086285571,0.0214577114087668,0.0832968557816022,0.314473474886005,-0.0797740133845145,0.246367724947719,"negative","no","no"
"Folate Metabolism",-0.189719059046163,0.000637256380732992,-0.297894386520203,-0.0815437315721217,-0.123961687438402,0.0944385273083923,-0.269381086285571,0.0214577114087668,0.0832968557816022,0.314473474886005,-0.0797740133845145,0.246367724947719,"negative","no","no"
"Fructose-1,6-diphosphatase Deficiency",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Fructose and Mannose Degradation",-0.260838049155994,1.98017011022688e-08,-0.349835017792753,-0.171841080519235,-0.314167972183383,1.31708388109354e-07,-0.428184353287772,-0.200151591078995,-0.0261532887220116,0.696726411298248,-0.158484379803971,0.106177802359948,"negative","no","negative"
"Fructose Intolerance, Hereditary",-0.260838049155994,1.98017011022688e-08,-0.349835017792753,-0.171841080519235,-0.314167972183383,1.31708388109354e-07,-0.428184353287772,-0.200151591078995,-0.0261532887220116,0.696726411298248,-0.158484379803971,0.106177802359948,"negative","no","negative"
"Fructosuria",-0.260838049155994,1.98017011022688e-08,-0.349835017792753,-0.171841080519235,-0.314167972183383,1.31708388109354e-07,-0.428184353287772,-0.200151591078995,-0.0261532887220116,0.696726411298248,-0.158484379803971,0.106177802359948,"negative","no","negative"
"Fumarase Deficiency",-0.180772782799269,4.03200419098862e-06,-0.256532331476725,-0.105013234121814,-0.0784569223215231,0.112804422418315,-0.175554585287608,0.018640740644562,0.103985623474905,0.0489016635272654,0.000507182032320322,0.207464064917491,"negative","no","no"
"G",-0.109541315031701,0.00301671408032004,-0.181630811862178,-0.0374518182012248,-0.0732199142792971,0.105603158952855,-0.162004019164986,0.0155641906063914,0.0391412968831269,0.487434028051727,-0.0719561529470854,0.150238746713339,"negative","no","no"
"GABA-Transaminase Deficiency",-0.489188893230055,6.79047445290677e-37,-0.555189121086438,-0.423188665373672,-0.187178654061121,5.19235779123498e-05,-0.276743301827668,-0.0976140062945739,0.324762160263937,5.28800235203647e-10,0.228140186298039,0.421384134229835,"negative","negative","negative"
"Galactose Metabolism",0.128633209038475,0.00200133763482812,0.0474269535494877,0.209839464527462,-0.259275307379221,3.09481684807553e-06,-0.366349694749148,-0.152200920009294,-0.368899720452435,1.36044634474028e-08,-0.490253338250267,-0.247546102654603,"positive","positive","negative"
"Galactosemia",0.128633209038475,0.00200133763482812,0.0474269535494877,0.209839464527462,-0.259275307379221,3.09481684807553e-06,-0.366349694749148,-0.152200920009294,-0.368899720452435,1.36044634474028e-08,-0.490253338250267,-0.247546102654603,"positive","positive","negative"
"Galactosemia II ",-0.0982689609995051,0.0574014529909419,-0.199645697952206,0.00310777595319534,-0.255108044646946,0.000211810809528593,-0.388799179141685,-0.121416910152208,-0.139998808167956,0.0655996595270215,-0.289144363588159,0.00914674725224773,"no","no","negative"
"Galactosemia III",-0.0982689609995051,0.0574014529909419,-0.199645697952206,0.00310777595319534,-0.255108044646946,0.000211810809528593,-0.388799179141685,-0.121416910152208,-0.139998808167956,0.0655996595270215,-0.289144363588159,0.00914674725224773,"no","no","negative"
"gamma-Cystathionase Deficiency ",-0.145016602743483,0.00379705057301919,-0.242843224851704,-0.047189980635263,-0.0559966516245408,0.373876616062974,-0.17978119431144,0.0677878910623589,0.096482723683855,0.170955211001662,-0.0420882050287231,0.235053652396433,"negative","no","no"
"gamma-Glutamyltransferase Deficiency",-0.35609441491958,5.80996653422029e-14,-0.444998242629957,-0.267190587209203,-0.204845032811655,0.00119796930017689,-0.327993667756627,-0.0816963978666841,0.183476018986936,0.00105868950567091,0.0749113421461793,0.292040695827692,"negative","negative","negative"
"gamma-Glutamyltranspeptidase Deficiency",-0.35609441491958,5.80996653422029e-14,-0.444998242629957,-0.267190587209203,-0.204845032811655,0.00119796930017689,-0.327993667756627,-0.0816963978666841,0.183476018986936,0.00105868950567091,0.0749113421461793,0.292040695827692,"negative","negative","negative"
"Gaucher Disease",0.116922901945543,0.0317547904360174,0.0102776092821764,0.22356819460891,-0.271607706826322,0.00024487512935041,-0.415416967218206,-0.127798446434438,-0.397932524248507,7.6463545094452e-07,-0.550294121354985,-0.245570927142029,"no","positive","negative"
"Gentamicin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Globoid Cell Leukodystrophy",0.116922901945543,0.0317547904360174,0.0102776092821764,0.22356819460891,-0.271607706826322,0.00024487512935041,-0.415416967218206,-0.127798446434438,-0.397932524248507,7.6463545094452e-07,-0.550294121354985,-0.245570927142029,"no","positive","negative"
"Gluconeogenesis",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Glucose-6-phosphate Dehydrogenase Deficiency",-0.265350019850992,3.73237388532973e-08,-0.357802167122099,-0.172897872579886,-0.198657752740886,0.000890964687523081,-0.315023750299795,-0.0822917551819772,0.0738593160688275,0.291702429027354,-0.064059611090453,0.211778243228108,"negative","no","negative"
"Glucose-Alanine Cycle",-0.663559209084051,1.2480076795396e-44,-0.742057346143966,-0.585061072024136,-0.0735270791539693,0.199176324898688,-0.186008023701487,0.0389538653935485,0.605444771092817,2.25072463050675e-26,0.513345831847029,0.697543710338604,"negative","negative","no"
"GLUT-1 Deficiency Syndrome",0.305072512881674,3.20200612901307e-09,0.206675686446889,0.403469339316459,-0.25634786514632,0.000129084429569322,-0.386230510295521,-0.126465219997119,-0.543146813106181,1.09353104647186e-11,-0.688932564915826,-0.397361061296537,"positive","positive","negative"
"Glutamate Metabolism",-0.374420687122854,8.02888392384289e-33,-0.429040812509613,-0.319800561736095,-0.0767070351514197,0.0495769072255869,-0.153271119420699,-0.000142950882140308,0.316029086275747,3.35861762249219e-15,0.244885475141182,0.387172697410312,"negative","negative","no"
"Glutaminolysis and Cancer",-0.290878376706399,3.13929878698286e-23,-0.343876583811801,-0.237880169600998,-0.162919564258164,5.49992562656868e-06,-0.232047041980129,-0.0937920865361995,0.137452579168247,0.000201676637842842,0.0661742000305249,0.20873095830597,"negative","negative","negative"
"Glutaric Aciduria Type I",-0.322261336371996,3.76560987146698e-21,-0.384529643292767,-0.259993029451226,-0.208959528038767,5.72231279012745e-06,-0.297791843025415,-0.120127213052119,0.11124963014181,0.00379767757813309,0.036487675186195,0.186011585097425,"negative","negative","negative"
"Glutathione Metabolism",-0.35609441491958,5.80996653422029e-14,-0.444998242629957,-0.267190587209203,-0.204845032811655,0.00119796930017689,-0.327993667756627,-0.0816963978666841,0.183476018986936,0.00105868950567091,0.0749113421461793,0.292040695827692,"negative","negative","negative"
"Glutathione Synthetase Deficiency",-0.35609441491958,5.80996653422029e-14,-0.444998242629957,-0.267190587209203,-0.204845032811655,0.00119796930017689,-0.327993667756627,-0.0816963978666841,0.183476018986936,0.00105868950567091,0.0749113421461793,0.292040695827692,"negative","negative","negative"
"Glycerol Kinase Deficiency",-0.00475568715682979,0.916974770080633,-0.0944524454917242,0.0849410711780646,-0.0872859734311423,0.153030025775695,-0.207219014568239,0.0326470677059548,-0.0540044753863623,0.413587916916845,-0.184150997329432,0.0761420465567075,"no","no","no"
"Glycerol Phosphate Shuttle",-0.316584861840354,3.13698508308083e-09,-0.418633282031252,-0.214536441649455,-0.0683100563252894,0.320362077220844,-0.203412202314593,0.0667920896640142,0.269789045137034,0.000282885784946978,0.126401790592728,0.41317629968134,"negative","negative","no"
"Glycerolipid Metabolism",-0.00475568715682979,0.916974770080633,-0.0944524454917242,0.0849410711780646,-0.0872859734311423,0.153030025775695,-0.207219014568239,0.0326470677059548,-0.0540044753863623,0.413587916916845,-0.184150997329432,0.0761420465567075,"no","no","no"
"Glycine and Serine Metabolism",-0.268858752062275,1.55604190596487e-19,-0.32344167948569,-0.214275824638859,-0.085160054872912,0.0229699461040202,-0.158467937938359,-0.0118521718074652,0.174954878047603,2.10183473383534e-06,0.104900070575799,0.245009685519407,"negative","negative","no"
"Glycine N-Methyltransferase Deficiency",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Glycogen Storage Disease Type 1A ",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Glycogen Synthetase Deficiency",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Glycogenosis, Type IA. Von Gierke Disease",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Glycogenosis, Type IB",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Glycogenosis, Type IC",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Glycogenosis, Type IV. Amylopectinosis, Anderson Disease",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Glycogenosis, Type VI. Hers Disease",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Glycogenosis, Type VII. Tarui Disease",-0.315212581075567,3.84684980215976e-12,-0.400962233135364,-0.229462929015769,-0.148842810706486,0.00917591483915739,-0.260494334232225,-0.0371912871807475,0.182282779930143,0.00388361326610506,0.0594784407969867,0.305087119063299,"negative","negative","negative"
"Glycolysis",-0.315212581075567,3.84684980215976e-12,-0.400962233135364,-0.229462929015769,-0.148842810706486,0.00917591483915739,-0.260494334232225,-0.0371912871807475,0.182282779930143,0.00388361326610506,0.0594784407969867,0.305087119063299,"negative","negative","negative"
"Gout or Kelley-Seegmiller Syndrome",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Guanidinoacetate Methyltransferase Deficiency ",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Hawkinsinuria",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"Hereditary Coproporphyria ",-0.657579932032959,2.62706059132273e-42,-0.738345748720594,-0.576814115345324,-0.291476592541191,8.99235998223182e-07,-0.405506689731086,-0.177446495351295,0.355711490769724,1.36469168874233e-08,0.238684081443949,0.472738900095498,"negative","negative","negative"
"Histidine Metabolism",-0.452483251430973,3.45998107332396e-30,-0.522212922259258,-0.382753580602687,-0.277622205855649,6.98581763559425e-08,-0.376106804055308,-0.17913760765599,0.193597832683602,6.70757415111725e-05,0.1003192877451,0.286876377622104,"negative","negative","negative"
"Histidinemia",-0.452483251430973,3.45998107332396e-30,-0.522212922259258,-0.382753580602687,-0.277622205855649,6.98581763559425e-08,-0.376106804055308,-0.17913760765599,0.193597832683602,6.70757415111725e-05,0.1003192877451,0.286876377622104,"negative","negative","negative"
"Homocarnosinosis",-0.374420687122854,8.02888392384289e-33,-0.429040812509613,-0.319800561736095,-0.0767070351514197,0.0495769072255869,-0.153271119420699,-0.000142950882140308,0.316029086275747,3.35861762249219e-15,0.244885475141182,0.387172697410312,"negative","negative","no"
"Homocysteine Degradation",-0.145016602743483,0.00379705057301919,-0.242843224851704,-0.047189980635263,-0.0559966516245408,0.373876616062974,-0.17978119431144,0.0677878910623589,0.096482723683855,0.170955211001662,-0.0420882050287231,0.235053652396433,"negative","no","no"
"Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Homocystinuria, Cystathionine beta-Synthase Deficiency",-0.145016602743483,0.00379705057301919,-0.242843224851704,-0.047189980635263,-0.0559966516245408,0.373876616062974,-0.17978119431144,0.0677878910623589,0.096482723683855,0.170955211001662,-0.0420882050287231,0.235053652396433,"negative","no","no"
"Hydrocodone Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Hydromorphone Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Hyper-IgD Syndrome",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Hypercholesterolemia",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Hyperglycinemia, Non-Ketotic",-0.268858752062275,1.55604190596487e-19,-0.32344167948569,-0.214275824638859,-0.085160054872912,0.0229699461040202,-0.158467937938359,-0.0118521718074652,0.174954878047603,2.10183473383534e-06,0.104900070575799,0.245009685519407,"negative","negative","no"
"Hyperinsulinism-Hyperammonemia Syndrome",-0.374420687122854,8.02888392384289e-33,-0.429040812509613,-0.319800561736095,-0.0767070351514197,0.0495769072255869,-0.153271119420699,-0.000142950882140308,0.316029086275747,3.35861762249219e-15,0.244885475141182,0.387172697410312,"negative","negative","no"
"Hyperlysinemia I, Familial",-0.620343502867699,2.82758844017656e-41,-0.697855076764188,-0.54283192897121,-0.384908418208681,1.23047741421851e-11,-0.49176044131948,-0.278056395097881,0.232042808191472,8.6964418393775e-07,0.142705899784322,0.321379716598622,"negative","negative","negative"
"Hyperlysinemia II or Saccharopinuria",-0.620343502867699,2.82758844017656e-41,-0.697855076764188,-0.54283192897121,-0.384908418208681,1.23047741421851e-11,-0.49176044131948,-0.278056395097881,0.232042808191472,8.6964418393775e-07,0.142705899784322,0.321379716598622,"negative","negative","negative"
"Hypermethioninemia",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Hyperornithinemia with Gyrate Atrophy ",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Hyperprolinemia Type I",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Hyperprolinemia Type II",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Hypoacetylaspartia",-0.247268583164232,5.74933323208967e-18,-0.300135099262824,-0.19440206706564,-0.238710901568552,1.17575890044112e-09,-0.313178268512804,-0.164243534624299,0.0170482816131327,0.625442979441999,-0.0518135270945629,0.0859100903208282,"negative","no","negative"
"Ibandronate Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Ibuprofen Action Pathway",0.169298568163877,0.00026966586369893,0.0789178908378665,0.259679245489888,-0.0640092696721599,0.299265047647574,-0.185192507108407,0.0571739677640876,-0.221753771454006,0.000214174801240175,-0.337242919654099,-0.106264623253914,"positive","positive","no"
"Imipramine Action Pathway",-0.289418481004223,5.72127366110328e-07,-0.400884260933194,-0.177952701075252,-0.212279144544385,0.00538940327791996,-0.361230111825127,-0.0633281772636427,0.0773833403283189,0.324320925163205,-0.077235373091814,0.232002053748452,"negative","no","negative"
"Indomethacin Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Inositol Metabolism",-0.203864178836396,2.28141486643019e-05,-0.297108498025465,-0.110619859647328,-0.245226486273225,7.15812731468096e-05,-0.364878079272329,-0.12557489327412,-0.041625876856295,0.540147271325806,-0.175577002227452,0.0923252485148623,"negative","no","negative"
"Inositol Phosphate Metabolism",-0.290257932081787,4.22997586502956e-08,-0.391816746014497,-0.188699118149078,-0.319094172013547,3.53800839095767e-06,-0.451689761450721,-0.186498582576374,-0.0257488750508744,0.745463515681348,-0.182179426359342,0.130681676257593,"negative","no","negative"
"Intracellular Signalling Through Adenosine Receptor A2a and Adenosine",-0.0753126855653569,0.165501116935683,-0.181920202468126,0.0312948313374122,-0.29939199473562,3.72834758277216e-05,-0.439893216869193,-0.158890772602048,-0.208566101194289,0.0135024704174761,-0.373425931001911,-0.0437062713866679,"no","no","negative"
"Intracellular Signalling Through Adenosine Receptor A2b and Adenosine",-0.0753126855653569,0.165501116935683,-0.181920202468126,0.0312948313374122,-0.29939199473562,3.72834758277216e-05,-0.439893216869193,-0.158890772602048,-0.208566101194289,0.0135024704174761,-0.373425931001911,-0.0437062713866679,"no","no","negative"
"Isobutyryl-CoA Dehydrogenase Deficiency",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Isovaleric Acidemia",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Isovaleric Aciduria",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Josamycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Joubert Syndrome",-0.0299084845659415,0.610777322165845,-0.145423362363168,0.0856063932312851,-0.243037690557824,0.00178317040126772,-0.394642307483102,-0.0914330736325459,-0.207665278588537,0.0216680180460301,-0.384503959523947,-0.0308265976531266,"no","no","negative"
"Kanamycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Ketobemidone  Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Ketone Body Metabolism",-0.336274625596489,9.72507089800011e-09,-0.448445154749267,-0.224104096443711,-0.230859375990116,0.00231987297594789,-0.378636073335003,-0.0830826786452283,0.101677794655294,0.16585446880159,-0.0426038691450301,0.245959458455618,"negative","no","negative"
"Ketoprofen Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Ketorolac Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Krabbe Disease",0.116922901945543,0.0317547904360174,0.0102776092821764,0.22356819460891,-0.271607706826322,0.00024487512935041,-0.415416967218206,-0.127798446434438,-0.397932524248507,7.6463545094452e-07,-0.550294121354985,-0.245570927142029,"no","positive","negative"
"L-Arginine:Glycine Amidinotransferase Deficiency",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Lactic Acidemia",-0.0980723140418954,0.00173968572410471,-0.159154337092555,-0.036990290991236,0.087287565902616,0.0439717484139801,0.00237478244419473,0.172200349361037,0.185378035881885,3.71066709752225e-06,0.109140744930435,0.261615326833334,"negative","negative","no"
"Lactose Synthesis",0.305072512881674,3.20200612901307e-09,0.206675686446889,0.403469339316459,-0.25634786514632,0.000129084429569322,-0.386230510295521,-0.126465219997119,-0.543146813106181,1.09353104647186e-11,-0.688932564915826,-0.397361061296537,"positive","positive","negative"
"Leigh Syndrome",-0.386425778769183,4.83668931443638e-22,-0.459190609198864,-0.313660948339502,-0.0365916387001459,0.457848088424243,-0.133501461276549,0.0603181838762575,0.354891039720559,4.78168841852519e-11,0.256009863457785,0.453772215983333,"negative","negative","no"
"Lesch-Nyhan Syndrome ",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Leukotriene C4 Synthesis Deficiency",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Levallorphan Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Levobupivacaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Levomethadyl Acetate Action Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Levorphanol Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Lincomycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Long Chain Acyl-CoA Dehydrogenase Deficiency ",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Lornoxicam Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Lovastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Lumiracoxib Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Lymecycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Lysine Degradation",-0.620343502867699,2.82758844017656e-41,-0.697855076764188,-0.54283192897121,-0.384908418208681,1.23047741421851e-11,-0.49176044131948,-0.278056395097881,0.232042808191472,8.6964418393775e-07,0.142705899784322,0.321379716598622,"negative","negative","negative"
"Lysosomal Acid Lipase Deficiency ",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Magnesium Salicylate Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Malate-Aspartate Shuttle",-0.339654862238459,4.24391502886968e-10,-0.44318048537348,-0.236129239103437,-0.138636939536282,0.0447964216924401,-0.274030332461598,-0.00324354661096696,0.215726400684885,0.00342466229280281,0.072399393683185,0.359053407686585,"negative","negative","no"
"Malonic Aciduria",-0.295564365635707,2.05866550996101e-14,-0.367931476998231,-0.223197254273183,-0.308676345208082,3.05000307642035e-10,-0.401476376595721,-0.215876313820444,-0.0183584594294788,0.722568685343744,-0.120336479501182,0.0836195606422247,"negative","no","negative"
"Malonyl-CoA Decarboxylase Deficiency",-0.295564365635707,2.05866550996101e-14,-0.367931476998231,-0.223197254273183,-0.308676345208082,3.05000307642035e-10,-0.401476376595721,-0.215876313820444,-0.0183584594294788,0.722568685343744,-0.120336479501182,0.0836195606422247,"negative","no","negative"
"Maple Syrup Urine Disease",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Medium Chain Acyl-CoA Dehydrogenase Deficiency ",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Mefenamic Acid Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Meloxicam Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Mepivacaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Mercaptopurine Action Pathway",-0.234077698349451,3.99487673551835e-15,-0.289718307010266,-0.178437089688636,0.0472018199643012,0.21569378762083,-0.0276890174055213,0.122092657334124,0.295154473770948,1.35902735494952e-12,0.219765105179077,0.370543842362818,"negative","negative","no"
"Mercaptopurine Metabolism Pathway",-0.742881998522269,6.09672727958454e-55,-0.818417260064227,-0.667346736980311,-0.472099466930619,2.30170254719862e-16,-0.578058881597649,-0.36614005226359,0.281467475269291,2.55119337001268e-08,0.18687280659596,0.376062143942623,"negative","negative","negative"
"Metachromatic Leukodystrophy ",0.116922901945543,0.0317547904360174,0.0102776092821764,0.22356819460891,-0.271607706826322,0.00024487512935041,-0.415416967218206,-0.127798446434438,-0.397932524248507,7.6463545094452e-07,-0.550294121354985,-0.245570927142029,"no","positive","negative"
"Methacycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Methadone Action Pathway",-0.289418481004223,5.72127366110328e-07,-0.400884260933194,-0.177952701075252,-0.212279144544385,0.00538940327791996,-0.361230111825127,-0.0633281772636427,0.0773833403283189,0.324320925163205,-0.077235373091814,0.232002053748452,"negative","no","negative"
"Methadyl Acetate Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Methionine Adenosyltransferase Deficiency",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Methionine Metabolism",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Methotrexate Action Pathway",-0.189719059046163,0.000637256380732992,-0.297894386520203,-0.0815437315721217,-0.123961687438402,0.0944385273083923,-0.269381086285571,0.0214577114087668,0.0832968557816022,0.314473474886005,-0.0797740133845145,0.246367724947719,"negative","no","no"
"Methylenetetrahydrofolate Reductase Deficiency ",-0.103389661409798,0.00107070166317329,-0.164984926384978,-0.0417943964346183,0.0076946080739704,0.846732467216905,-0.0706147960106893,0.0860040121586302,0.112380129501645,0.0129966887005967,0.0240472016339402,0.20071305736935,"negative","no","no"
"Methylhistidine Metabolism",-0.61153571044567,2.58116300644412e-35,-0.696507637123456,-0.526563783767885,-0.465995944510763,1.18214417104392e-13,-0.583098423147003,-0.348893465874523,0.173186860355663,0.000406362797145423,0.0785719128853865,0.26780180782594,"negative","negative","negative"
"Methylmalonate Semialdehyde Dehydrogenase Deficiency",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Methylmalonic Aciduria",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Methylmalonic Aciduria Due to Cobalamin-Related Disorders",-0.295564365635707,2.05866550996101e-14,-0.367931476998231,-0.223197254273183,-0.308676345208082,3.05000307642035e-10,-0.401476376595721,-0.215876313820444,-0.0183584594294788,0.722568685343744,-0.120336479501182,0.0836195606422247,"negative","no","negative"
"Mevalonic Aciduria",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Minocycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids",-0.417433685688119,2.03599691146647e-12,-0.529431007344168,-0.30543636403207,-0.149244911376291,0.0560442016251673,-0.302366575655754,0.00387675290317172,0.25473015865044,0.00257979135734199,0.090518280516366,0.418942036784514,"negative","negative","no"
"Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids",-0.417433685688119,2.03599691146647e-12,-0.529431007344168,-0.30543636403207,-0.149244911376291,0.0560442016251673,-0.302366575655754,0.00387675290317172,0.25473015865044,0.00257979135734199,0.090518280516366,0.418942036784514,"negative","negative","no"
"Mitochondrial Complex II Deficiency",-0.180772782799269,4.03200419098862e-06,-0.256532331476725,-0.105013234121814,-0.0784569223215231,0.112804422418315,-0.175554585287608,0.018640740644562,0.103985623474905,0.0489016635272654,0.000507182032320322,0.207464064917491,"negative","no","no"
"Mitochondrial DNA Depletion Syndrome",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Mitochondrial Electron Transport Chain",-0.139339068529878,0.00366372205493098,-0.232968230203864,-0.045709906855892,-0.160463628938494,0.00973512397892152,-0.281791290950346,-0.0391359669266407,0.00172463949814817,0.978837887653837,-0.126523672722817,0.129972951719113,"negative","no","negative"
"MNGIE ",-0.201664344141794,6.41701068234481e-09,-0.268076385489351,-0.135252302794238,-0.238361677290802,4.67245188355955e-08,-0.321743906122532,-0.154979448459072,-0.0443083534282575,0.39930874938211,-0.147880580722982,0.0592638738664673,"negative","no","negative"
"Molybdenum Cofactor Deficiency",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Monoamine Oxidase-A Deficiency ",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"Morphine Action Pathway",-0.0244641118238587,0.684038322842813,-0.14264391996795,0.0937156963202322,-0.19369958924438,0.0142996715419893,-0.348357074283,-0.039042104205759,-0.17683701969016,0.0406001383587739,-0.346007212895163,-0.00766682648515582,"no","no","no"
"Mucopolysaccharidosis VII. Sly Syndrome",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Multiple Carboxylase Deficiency, Neonatal or Early Onset Form",-0.0535768514206945,0.231184741839705,-0.141454846261855,0.0343011434204661,-0.331819512852461,3.19199252352411e-07,-0.456329870415348,-0.207309155289573,-0.257811677355895,6.52318225007046e-05,-0.381812740817065,-0.133810613894725,"no","positive","negative"
"Mycophenolic Acid Metabolism Pathway",-0.37795968499118,1.08468358297341e-10,-0.48916504783422,-0.26675432214814,-0.377739376166937,7.84300451713364e-07,-0.524679143144411,-0.230799609189463,-0.0118277077903479,0.891629359839273,-0.183064639415899,0.159409223835203,"negative","no","negative"
"Myoadenylate Deaminase Deficiency",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Nabumetone Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Nalbuphine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Naloxone Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Naltrexone Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Naproxen Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Neomycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Nepafenac Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Netilmicin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Nicotinate and Nicotinamide Metabolism",-0.745055306915802,3.98298124347354e-66,-0.810653940610605,-0.679456673220999,-0.419261774610384,5.63895283705185e-16,-0.514789899536794,-0.323733649683975,0.332451179200067,2.83824695453427e-10,0.235268280521594,0.42963407787854,"negative","negative","negative"
"Nicotine Action Pathway",-0.242191712537503,1.3014365117396e-05,-0.349708479722094,-0.134674945352912,-0.222325630211154,0.00235924592301492,-0.364880980588343,-0.0797702798339648,0.0143651283907423,0.85383460628306,-0.139433746074371,0.168164002855856,"negative","no","negative"
"Non-Ketotic Hyperglycinemia",-0.268858752062275,1.55604190596487e-19,-0.32344167948569,-0.214275824638859,-0.085160054872912,0.0229699461040202,-0.158467937938359,-0.0118521718074652,0.174954878047603,2.10183473383534e-06,0.104900070575799,0.245009685519407,"negative","negative","no"
"Nucleotide Sugars Metabolism",-0.0982689609995051,0.0574014529909419,-0.199645697952206,0.00310777595319534,-0.255108044646946,0.000211810809528593,-0.388799179141685,-0.121416910152208,-0.139998808167956,0.0655996595270215,-0.289144363588159,0.00914674725224773,"no","no","negative"
"Ornithine Aminotransferase Deficiency ",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Ornithine Transcarbamylase Deficiency ",-0.316417379674907,2.90531115557552e-26,-0.369755893553278,-0.263078865796536,-0.0583177485425949,0.141909714864677,-0.136267370240607,0.0196318731554168,0.264280168738924,1.22602393536328e-13,0.200276295732321,0.328284041745527,"negative","negative","no"
"Oxaprozin Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Oxidation of Branched-Chain Fatty Acids",-0.0686577294066807,0.0694459322158256,-0.142811780334297,0.00549632152093588,-0.291338218731289,4.21913378652043e-08,-0.392896571376231,-0.189779866086348,-0.203100747337962,1.06130204179523e-05,-0.291149520421394,-0.11505197425453,"no","positive","negative"
"Oxybuprocaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Oxycodone Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Oxymorphone Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Oxytetracycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Pamidronate Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Pantothenate and CoA Biosynthesis",-0.26876233475971,8.43856739609944e-11,-0.347344748877578,-0.190179920641841,-0.207174717892858,0.000187057370721935,-0.314809580936513,-0.0995398548492025,0.0634618816897498,0.242043001205681,-0.0432965053189109,0.170220268698411,"negative","no","negative"
"Paromomycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Pentazocine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Pentose Phosphate Pathway",-0.265350019850992,3.73237388532973e-08,-0.357802167122099,-0.172897872579886,-0.198657752740886,0.000890964687523081,-0.315023750299795,-0.0822917551819772,0.0738593160688275,0.291702429027354,-0.064059611090453,0.211778243228108,"negative","no","negative"
"Phenylacetate Metabolism",-0.527070167361823,1.40380738286222e-23,-0.622203755962403,-0.431936578761243,-0.404775468182194,1.84210175839504e-09,-0.532677669601066,-0.276873266763321,0.124991572581722,0.0928380934774573,-0.0210232869386233,0.271006432102067,"negative","no","negative"
"Phenylalanine and Tyrosine Metabolism",-0.179723732147256,1.57376631271482e-06,-0.251924543126425,-0.107522921168086,-0.0467694440393272,0.34307620767557,-0.143727061120371,0.0501881730417166,0.14013742463604,0.00307389875530277,0.0481135260941903,0.232161323177889,"negative","negative","no"
"Phenylbutazone Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Phenylketonuria",-0.179723732147256,1.57376631271482e-06,-0.251924543126425,-0.107522921168086,-0.0467694440393272,0.34307620767557,-0.143727061120371,0.0501881730417166,0.14013742463604,0.00307389875530277,0.0481135260941903,0.232161323177889,"negative","negative","no"
"Phenytoin ",-0.476874112090397,1.2411894679756e-23,-0.562824765139385,-0.390923459041408,-0.559734456668971,6.92051105872904e-20,-0.670848438385365,-0.448620474952578,-0.0715843086302535,0.26354631863948,-0.197615787006686,0.0544471697461796,"negative","no","negative"
"Phosphatidylcholine Biosynthesis",-0.331617127614867,1.48767145121223e-16,-0.406188215449988,-0.257046039779746,-0.402081141077123,2.38314660611236e-14,-0.500042749755621,-0.304119532398624,-0.0483096337295735,0.391430810799517,-0.159363566111077,0.0627442986519297,"negative","no","negative"
"Phosphatidylcholine Biosynthesis PC",-0.331617127614867,1.48767145121223e-16,-0.406188215449988,-0.257046039779746,-0.402081141077123,2.38314660611236e-14,-0.500042749755621,-0.304119532398624,-0.0483096337295735,0.391430810799517,-0.159363566111077,0.0627442986519297,"negative","no","negative"
"Phosphatidylethanolamine Biosynthesis",0.159221859584665,0.000864783807839646,0.0661009628771727,0.252342756292158,-0.128807070127043,0.0453587800484533,-0.254933058767158,-0.00268108148692875,-0.286817021581744,7.84821088569891e-05,-0.426390232533019,-0.14724381063047,"positive","positive","no"
"Phosphatidylethanolamine Biosynthesis PE",0.159221859584665,0.000864783807839646,0.0661009628771727,0.252342756292158,-0.128807070127043,0.0453587800484533,-0.254933058767158,-0.00268108148692875,-0.286817021581744,7.84821088569891e-05,-0.426390232533019,-0.14724381063047,"positive","positive","no"
"Phosphatidylinositol Phosphate Metabolism",-0.0299084845659415,0.610777322165845,-0.145423362363168,0.0856063932312851,-0.243037690557824,0.00178317040126772,-0.394642307483102,-0.0914330736325459,-0.207665278588537,0.0216680180460301,-0.384503959523947,-0.0308265976531266,"no","no","negative"
"Phosphoenolpyruvate Carboxykinase Deficiency 1 ",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Phospholipid Biosynthesis",-0.0805406792252555,0.0510608432855808,-0.161455080411599,0.000373721961088216,0.070361712928272,0.205661069612217,-0.0388394839047379,0.179562909761282,0.16810491112677,0.00499650842746037,0.0515273852195262,0.284682437034014,"no","negative","no"
"Phytanic Acid Peroxisomal Oxidation",-0.378600972318612,1.35252177436923e-13,-0.474681765287295,-0.28252017934993,-0.467101380133293,3.59332488666065e-12,-0.593191902202542,-0.341010858064044,-0.0724032922979167,0.280026378749677,-0.204354012245765,0.0595474276499314,"negative","no","negative"
"Piroxicam Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Porphyria Variegata ",-0.657579932032959,2.62706059132273e-42,-0.738345748720594,-0.576814115345324,-0.291476592541191,8.99235998223182e-07,-0.405506689731086,-0.177446495351295,0.355711490769724,1.36469168874233e-08,0.238684081443949,0.472738900095498,"negative","negative","negative"
"Porphyrin Metabolism",-0.657579932032959,2.62706059132273e-42,-0.738345748720594,-0.576814115345324,-0.291476592541191,8.99235998223182e-07,-0.405506689731086,-0.177446495351295,0.355711490769724,1.36469168874233e-08,0.238684081443949,0.472738900095498,"negative","negative","negative"
"Pravastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Prilocaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Primary Hyperoxaluria II, PH2",-0.386425778769183,4.83668931443638e-22,-0.459190609198864,-0.313660948339502,-0.0365916387001459,0.457848088424243,-0.133501461276549,0.0603181838762575,0.354891039720559,4.78168841852519e-11,0.256009863457785,0.453772215983333,"negative","negative","no"
"Primary Hyperoxaluria Type I",-0.0980723140418954,0.00173968572410471,-0.159154337092555,-0.036990290991236,0.087287565902616,0.0439717484139801,0.00237478244419473,0.172200349361037,0.185378035881885,3.71066709752225e-06,0.109140744930435,0.261615326833334,"negative","negative","no"
"Procaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Prolidase Deficiency ",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Prolinemia Type II",-0.169220895306476,5.26680514863332e-11,-0.218128328094752,-0.1203134625182,-0.172924122827083,5.41617219026019e-07,-0.239182393583438,-0.106665852070728,0.00108946185999417,0.971519403332993,-0.0591018144434542,0.0612807381634425,"negative","no","negative"
"Propanoate Metabolism",-0.295564365635707,2.05866550996101e-14,-0.367931476998231,-0.223197254273183,-0.308676345208082,3.05000307642035e-10,-0.401476376595721,-0.215876313820444,-0.0183584594294788,0.722568685343744,-0.120336479501182,0.0836195606422247,"negative","no","negative"
"Proparacaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Propionic Acidemia",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Propoxyphene Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Purine Metabolism",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Purine Nucleoside Phosphorylase Deficiency",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Pyridoxine Dependency with Seizures",-0.620343502867699,2.82758844017656e-41,-0.697855076764188,-0.54283192897121,-0.384908418208681,1.23047741421851e-11,-0.49176044131948,-0.278056395097881,0.232042808191472,8.6964418393775e-07,0.142705899784322,0.321379716598622,"negative","negative","negative"
"Pyrimidine Metabolism",-0.201664344141794,6.41701068234481e-09,-0.268076385489351,-0.135252302794238,-0.238361677290802,4.67245188355955e-08,-0.321743906122532,-0.154979448459072,-0.0443083534282575,0.39930874938211,-0.147880580722982,0.0592638738664673,"negative","no","negative"
"Pyruvate Carboxylase Deficiency",-0.0980723140418954,0.00173968572410471,-0.159154337092555,-0.036990290991236,0.087287565902616,0.0439717484139801,0.00237478244419473,0.172200349361037,0.185378035881885,3.71066709752225e-06,0.109140744930435,0.261615326833334,"negative","negative","no"
"Pyruvate Decarboxylase E1 Component Deficiency ",-0.386425778769183,4.83668931443638e-22,-0.459190609198864,-0.313660948339502,-0.0365916387001459,0.457848088424243,-0.133501461276549,0.0603181838762575,0.354891039720559,4.78168841852519e-11,0.256009863457785,0.453772215983333,"negative","negative","no"
"Pyruvate Dehydrogenase Complex Deficiency",-0.386425778769183,4.83668931443638e-22,-0.459190609198864,-0.313660948339502,-0.0365916387001459,0.457848088424243,-0.133501461276549,0.0603181838762575,0.354891039720559,4.78168841852519e-11,0.256009863457785,0.453772215983333,"negative","negative","no"
"Pyruvate Dehydrogenase Deficiency ",-0.180772782799269,4.03200419098862e-06,-0.256532331476725,-0.105013234121814,-0.0784569223215231,0.112804422418315,-0.175554585287608,0.018640740644562,0.103985623474905,0.0489016635272654,0.000507182032320322,0.207464064917491,"negative","no","no"
"Pyruvate Kinase Deficiency",-0.386425778769183,4.83668931443638e-22,-0.459190609198864,-0.313660948339502,-0.0365916387001459,0.457848088424243,-0.133501461276549,0.0603181838762575,0.354891039720559,4.78168841852519e-11,0.256009863457785,0.453772215983333,"negative","negative","no"
"Pyruvate Metabolism",-0.386425778769183,4.83668931443638e-22,-0.459190609198864,-0.313660948339502,-0.0365916387001459,0.457848088424243,-0.133501461276549,0.0603181838762575,0.354891039720559,4.78168841852519e-11,0.256009863457785,0.453772215983333,"negative","negative","no"
"Refsum Disease",-0.378600972318612,1.35252177436923e-13,-0.474681765287295,-0.28252017934993,-0.467101380133293,3.59332488666065e-12,-0.593191902202542,-0.341010858064044,-0.0724032922979167,0.280026378749677,-0.204354012245765,0.0595474276499314,"negative","no","negative"
"Remifentanil Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Ribose-5-phosphate Isomerase Deficiency",-0.265350019850992,3.73237388532973e-08,-0.357802167122099,-0.172897872579886,-0.198657752740886,0.000890964687523081,-0.315023750299795,-0.0822917551819772,0.0738593160688275,0.291702429027354,-0.064059611090453,0.211778243228108,"negative","no","negative"
"Risedronate Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Rofecoxib Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Rolitetracycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Ropivacaine Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Rosuvastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Roxithromycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"S-Adenosylhomocysteine ",-0.153194820646098,1.20942774217355e-05,-0.220946143152618,-0.085443498139577,-0.0342303952024315,0.441464373398506,-0.121664588354491,0.0532037979496276,0.114643807827045,0.0196976607091516,0.0185485333243455,0.210739082329744,"negative","no","no"
"Saccharopinuria/Hyperlysinemia II",-0.620343502867699,2.82758844017656e-41,-0.697855076764188,-0.54283192897121,-0.384908418208681,1.23047741421851e-11,-0.49176044131948,-0.278056395097881,0.232042808191472,8.6964418393775e-07,0.142705899784322,0.321379716598622,"negative","negative","negative"
"Salicylate-Sodium Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Salicylic Acid Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Salla Disease/Infantile Sialic Acid Storage Disease",-0.109541315031701,0.00301671408032004,-0.181630811862178,-0.0374518182012248,-0.0732199142792971,0.105603158952855,-0.162004019164986,0.0155641906063914,0.0391412968831269,0.487434028051727,-0.0719561529470854,0.150238746713339,"negative","no","no"
"Salsalate Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Sarcosine Oncometabolite Pathway",-0.183622716957798,1.70571946148805e-06,-0.257648298777614,-0.109597135137983,-0.0476143961410483,0.328307551321131,-0.143347290256382,0.0481184979742859,0.125087214626383,0.0165901613886572,0.0230733889925608,0.227101040260206,"negative","no","no"
"Sarcosinemia",-0.268858752062275,1.55604190596487e-19,-0.32344167948569,-0.214275824638859,-0.085160054872912,0.0229699461040202,-0.158467937938359,-0.0118521718074652,0.174954878047603,2.10183473383534e-06,0.104900070575799,0.245009685519407,"negative","negative","no"
"Selenoamino Acid Metabolism",-0.128747934111986,0.00325614047836086,-0.214165859711456,-0.0433300085125154,-0.0480301048815951,0.421892297672779,-0.16560176726759,0.0695415575043994,0.0816845341586282,0.18156506748853,-0.0385653569626107,0.201934425279867,"negative","no","no"
"Short-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency ",-0.417433685688119,2.03599691146647e-12,-0.529431007344168,-0.30543636403207,-0.149244911376291,0.0560442016251673,-0.302366575655754,0.00387675290317172,0.25473015865044,0.00257979135734199,0.090518280516366,0.418942036784514,"negative","negative","no"
"Short-Chain Acyl-CoA Dehydrogenase Deficiency ",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Sialuria or French Type Sialuria",-0.109541315031701,0.00301671408032004,-0.181630811862178,-0.0374518182012248,-0.0732199142792971,0.105603158952855,-0.162004019164986,0.0155641906063914,0.0391412968831269,0.487434028051727,-0.0719561529470854,0.150238746713339,"negative","no","no"
"Simvastatin Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Smith-Lemli-Opitz Syndrome ",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Spectinomycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Spermidine and Spermine Biosynthesis",-0.135904382244702,0.00484601130357295,-0.230139086456102,-0.0416696780333009,-0.202018513828499,0.000420743492713961,-0.313362850069991,-0.0906741775870082,-0.0572973416052282,0.435549133089675,-0.202099418278728,0.0875047350682717,"negative","no","negative"
"Sphingolipid Metabolism",0.116922901945543,0.0317547904360174,0.0102776092821764,0.22356819460891,-0.271607706826322,0.00024487512935041,-0.415416967218206,-0.127798446434438,-0.397932524248507,7.6463545094452e-07,-0.550294121354985,-0.245570927142029,"no","positive","negative"
"Starch and Sucrose Metabolism",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Steroid Biosynthesis",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Streptomycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Succinate Signalling",-0.700265275965016,1.63878529862033e-53,-0.772886578829691,-0.627643973100342,-0.55732864043537,5.91382452311709e-23,-0.658269574868614,-0.456387706002125,0.163885775931252,6.16085497112066e-05,0.0853411960982117,0.242430355764292,"negative","negative","negative"
"Succinic Semialdehyde Dehydrogenase Deficiency",-0.374420687122854,8.02888392384289e-33,-0.429040812509613,-0.319800561736095,-0.0767070351514197,0.0495769072255869,-0.153271119420699,-0.000142950882140308,0.316029086275747,3.35861762249219e-15,0.244885475141182,0.387172697410312,"negative","negative","no"
"Succinyl CoA: 3-Ketoacid CoA Transferase Deficiency",-0.336274625596489,9.72507089800011e-09,-0.448445154749267,-0.224104096443711,-0.230859375990116,0.00231987297594789,-0.378636073335003,-0.0830826786452283,0.101677794655294,0.16585446880159,-0.0426038691450301,0.245959458455618,"negative","no","negative"
"Sucrase-Isomaltase Deficiency",0.162063297875901,8.29103293898921e-05,0.0821335729679131,0.24199302278389,-0.133757517753536,0.0107807940549973,-0.236313535264638,-0.0312015002424351,-0.285889793133398,2.48867422323604e-06,-0.401262788570252,-0.170516797696545,"positive","positive","no"
"Sufentanil Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Sulindac Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Suprofen Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Taurine and Hypotaurine Metabolism",-0.384140866268456,5.11472094813459e-12,-0.489301983441452,-0.278979749095461,-0.249998295535135,0.000604091012556,-0.391774349855007,-0.108222241215262,0.161948665292113,0.0318713389535577,0.0142290386665488,0.309668291917678,"negative","no","negative"
"Tay-Sachs Disease",-0.109541315031701,0.00301671408032004,-0.181630811862178,-0.0374518182012248,-0.0732199142792971,0.105603158952855,-0.162004019164986,0.0155641906063914,0.0391412968831269,0.487434028051727,-0.0719561529470854,0.150238746713339,"negative","no","no"
"Telithromycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Tenoxicam Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Tetracycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"The Oncogenic Action of 2-Hydroxyglutarate",-0.345442028610115,1.51448405490982e-21,-0.411421593171393,-0.279462464048837,-0.242001902397009,1.21621539073194e-07,-0.3295727610704,-0.154431043723619,0.106875355191247,0.0120865816110085,0.0237489792915726,0.190001731090921,"negative","no","negative"
"The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxygluaricaciduria",-0.345442028610115,1.51448405490982e-21,-0.411421593171393,-0.279462464048837,-0.242001902397009,1.21621539073194e-07,-0.3295727610704,-0.154431043723619,0.106875355191247,0.0120865816110085,0.0237489792915726,0.190001731090921,"negative","no","negative"
"The Oncogenic Action of Fumarate",-0.171789504087695,7.84466663032196e-08,-0.233193208734196,-0.110385799441195,-0.143549280431949,0.000585119771520513,-0.224747804132721,-0.0623507567311763,0.0302657621232204,0.464162521650701,-0.0512181577420477,0.111749681988489,"negative","no","negative"
"The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria",-0.345442028610115,1.51448405490982e-21,-0.411421593171393,-0.279462464048837,-0.242001902397009,1.21621539073194e-07,-0.3295727610704,-0.154431043723619,0.106875355191247,0.0120865816110085,0.0237489792915726,0.190001731090921,"negative","no","negative"
"The Oncogenic Action of Succinate",-0.171789504087695,7.84466663032196e-08,-0.233193208734196,-0.110385799441195,-0.143549280431949,0.000585119771520513,-0.224747804132721,-0.0623507567311763,0.0302657621232204,0.464162521650701,-0.0512181577420477,0.111749681988489,"negative","no","negative"
"Thioguanine Action Pathway",-0.234077698349451,3.99487673551835e-15,-0.289718307010266,-0.178437089688636,0.0472018199643012,0.21569378762083,-0.0276890174055213,0.122092657334124,0.295154473770948,1.35902735494952e-12,0.219765105179077,0.370543842362818,"negative","negative","no"
"Threonine and 2-Oxobutanoate Degradation",-0.347774651952111,5.93495991283902e-16,-0.427777896509866,-0.267771407394357,-0.31935267665407,8.65079603040445e-08,-0.43350259687964,-0.2052027564285,0.0276901758786668,0.624707356851538,-0.0839188987044291,0.139299250461763,"negative","no","negative"
"Tiaprofenic Acid Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Tigecycline Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Tobramycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Tolmetin Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Tramadol Action Action Pathway",-0.0248214836832338,0.697540588271884,-0.150380171718387,0.100737204351919,-0.166090714046545,0.0469658264985197,-0.329937258785082,-0.00224416930800792,-0.14383477611975,0.108460853385823,-0.319834392526854,0.0321648402873537,"no","no","no"
"Tramadol Metabolism Pathway",-0.37795968499118,1.08468358297341e-10,-0.48916504783422,-0.26675432214814,-0.377739376166937,7.84300451713364e-07,-0.524679143144411,-0.230799609189463,-0.0118277077903479,0.891629359839273,-0.183064639415899,0.159409223835203,"negative","no","negative"
"Transaldolase Deficiency",-0.265350019850992,3.73237388532973e-08,-0.357802167122099,-0.172897872579886,-0.198657752740886,0.000890964687523081,-0.315023750299795,-0.0822917551819772,0.0738593160688275,0.291702429027354,-0.064059611090453,0.211778243228108,"negative","no","negative"
"Transfer of Acetyl Groups into Mitochondria",-0.270167187223582,1.54789935908718e-09,-0.355495894890146,-0.184838479557019,0.00355698653092416,0.951269368009337,-0.110941312823635,0.118055285885483,0.274072828890807,5.39229254757392e-06,0.159286117186515,0.388859540595099,"negative","negative","no"
"Trifunctional Protein Deficiency",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Triosephosphate Isomerase Deficiency",-0.322437452082974,4.86640495717262e-15,-0.399349208157584,-0.245525696008363,-0.206144570569706,5.70348620161305e-05,-0.305341674427692,-0.10694746671172,0.12967222169281,0.0198934774576622,0.020803844492265,0.238540598893355,"negative","no","negative"
"Trisalicylate-Choline Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"tRNA Charging: Alanine",0.106654484605026,0.0338347818101553,0.00819955159399498,0.205109417616057,0.022560070569406,0.747351323455978,-0.115196245933506,0.160316387072318,-0.0919669030542341,0.208206463994179,-0.23573242982588,0.0517986237174121,"no","no","no"
"tRNA Charging: Arginine",0.244521378227028,1.27775162344761e-06,0.147164553121418,0.341878203332638,0.0627417532875445,0.371310939302881,-0.0752098336525087,0.200693340227598,-0.198857799550826,0.00706729003928127,-0.342728247072296,-0.0549873520293567,"positive","positive","no"
"tRNA Charging: Asparagine",-0.553955579332881,5.66746081807283e-26,-0.647999892916763,-0.459911265748998,-0.492852807494922,2.52879874135406e-13,-0.61860692088725,-0.367098694102595,0.0565594682996378,0.419512945015001,-0.081492325009169,0.194611261608445,"negative","no","negative"
"tRNA Charging: Cysteine",-0.308489586228318,1.90111864376894e-08,-0.413606247519652,-0.203372924936984,-0.158504146549525,0.0307876015951787,-0.302228305572705,-0.0147799875263439,0.179688018540259,0.0143220583829662,0.0364031207111501,0.322972916369368,"negative","no","no"
"tRNA Charging: Glutamine",-0.527070167361823,1.40380738286222e-23,-0.622203755962403,-0.431936578761243,-0.404775468182194,1.84210175839504e-09,-0.532677669601066,-0.276873266763321,0.124991572581722,0.0928380934774573,-0.0210232869386233,0.271006432102067,"negative","no","negative"
"tRNA Charging: Glycine",0.0152415720610084,0.76710664035641,-0.0859380331000598,0.116421177222077,-0.0392152758182515,0.590274505356533,-0.182450278037518,0.104019726401015,-0.0660566431461038,0.383837325239062,-0.215491182146173,0.0833778958539653,"no","no","no"
"tRNA Charging: Histidine",0.0110823729229688,0.83032855898277,-0.0906028150156432,0.112767560861581,-0.0294626583298436,0.680065259775006,-0.169989838978919,0.111064522319232,-0.0438986643045446,0.560051550768955,-0.19240216678608,0.10460483817699,"no","no","no"
"tRNA Charging: Isoleucine",0.0673122478521856,0.183106808327138,-0.0319590698544498,0.166583565558821,-0.0924126994193544,0.179558418840811,-0.227632817462643,0.0428074186239341,-0.168388993863593,0.0213283476740202,-0.311402440758158,-0.0253755469690284,"no","no","no"
"tRNA Charging: Leucine",0.0270309041029274,0.600814144136699,-0.074522231696187,0.128584039902042,-0.0450872854519918,0.530127432488636,-0.186312159930519,0.0961375890265356,-0.0836963234861429,0.265672963504117,-0.231712369154837,0.0643197221825514,"no","no","no"
"tRNA Charging: Lysine",-0.0117633710310912,0.821032427172601,-0.11400107860079,0.0904743365386071,-0.0496149426317945,0.493514762073964,-0.192093275952167,0.0928633906885782,-0.0373114909722676,0.616520587363506,-0.184214900923351,0.109591918978816,"no","no","no"
"tRNA Charging: Methionine",0.0155319597934661,0.760859777986607,-0.0848002667338919,0.115864186320824,0.300313613965944,2.44899637126672e-05,0.162684711548861,0.437942516383027,0.276054314836152,0.000217159046895748,0.132142673995861,0.419965955676442,"no","negative","positive"
"tRNA Charging: Phenylalanine",0.160514022396161,0.00152876956659462,0.0617521139251741,0.259275930867147,0.0392265623959627,0.577499422218814,-0.0992621619345014,0.177715286726427,-0.127337920030894,0.0876621999866976,-0.273697986420238,0.0190221463584495,"positive","no","no"
"tRNA Charging: Proline",0.0151707205910555,0.784163659857397,-0.0937261145998757,0.124067555781987,-0.079080242388597,0.302971297944922,-0.229950755683376,0.0717902709061816,-0.107459848103737,0.192659455617349,-0.269709351906905,0.05478965569943,"no","no","no"
"tRNA Charging: Serine",0.0608559878025677,0.238449205584589,-0.0405264890937806,0.162238464698916,-0.0168994577225496,0.815484123583913,-0.159355108432141,0.125556192987042,-0.0923236116723368,0.215248609369904,-0.238900411233595,0.054253187888921,"no","no","no"
"tRNA Charging: Threonine",0.000648904560823175,0.989981483867878,-0.100959448929009,0.102257258050656,-0.0263756939990848,0.713824598518029,-0.167843839889019,0.115092451890849,-0.0409446876690014,0.586688886347412,-0.189434395785959,0.107545020447956,"no","no","no"
"tRNA Charging: Tryptophan",-0.0142393935315413,0.779320204469339,-0.114149834244968,0.0856710471818858,-0.121197511898136,0.0896213031037425,-0.261271951825448,0.018876928029176,-0.112790141346194,0.129411523155057,-0.258945033134825,0.0333647504424378,"no","no","no"
"tRNA Charging: Tyrosine",0.0102083054096761,0.844970427110159,-0.0924344577081737,0.112851068527526,-0.060332541449515,0.411259471644853,-0.204683127159407,0.0840180442603774,-0.077499276263982,0.306169718785075,-0.226629708935855,0.0716311564078913,"no","no","no"
"tRNA Charging: Valine",0.0258004095154744,0.609193303225191,-0.0734070158613901,0.125007834892339,-0.0666057004732147,0.342121231212603,-0.204412410850244,0.071201009903815,-0.0980854592240217,0.19827379542695,-0.248064014252712,0.0518930958046691,"no","no","no"
"Troleandomycin Action Pathway",0.0379418523974174,0.399639373459472,-0.0505776912499954,0.12646139604483,0.0233849172869274,0.6919460037447,-0.0927036637565922,0.139473498330447,-0.00642654147940126,0.916475191715935,-0.12729755061411,0.114444467655308,"no","no","no"
"Tryptophan Metabolism",-0.21542260789999,3.90943826185299e-10,-0.280939328066756,-0.149905887733224,-0.175586039810246,8.4673231269133e-05,-0.262161170206744,-0.0890109094137471,0.0581962368931863,0.244669391706003,-0.0402535815012365,0.156646055287609,"negative","no","negative"
"Tyrosine Hydroxylase Deficiency",-0.313260932996422,1.28668602260984e-11,-0.400826730536599,-0.225695135456245,-0.201137375430878,0.000991510873093534,-0.320050019381108,-0.082224731480647,0.144884943754593,0.00379831091903905,0.0475175812835581,0.242252306225627,"negative","negative","negative"
"Tyrosine Metabolism",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"Tyrosinemia Type 2 ",-0.179723732147256,1.57376631271482e-06,-0.251924543126425,-0.107522921168086,-0.0467694440393272,0.34307620767557,-0.143727061120371,0.0501881730417166,0.14013742463604,0.00307389875530277,0.0481135260941903,0.232161323177889,"negative","negative","no"
"Tyrosinemia Type 3 ",-0.179723732147256,1.57376631271482e-06,-0.251924543126425,-0.107522921168086,-0.0467694440393272,0.34307620767557,-0.143727061120371,0.0501881730417166,0.14013742463604,0.00307389875530277,0.0481135260941903,0.232161323177889,"negative","negative","no"
"Tyrosinemia Type I",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"Tyrosinemia, Transient, of the Newborn",-0.285219146429297,7.36240681116153e-15,-0.353757427075244,-0.21668086578335,-0.130518382453477,0.00611281204880486,-0.223493782072385,-0.0375429828345685,0.169822622198391,3.26080998186047e-05,0.0914898335889484,0.248155410807834,"negative","negative","negative"
"UMP Synthase Deficiency ",-0.201664344141794,6.41701068234481e-09,-0.268076385489351,-0.135252302794238,-0.238361677290802,4.67245188355955e-08,-0.321743906122532,-0.154979448459072,-0.0443083534282575,0.39930874938211,-0.147880580722982,0.0592638738664673,"negative","no","negative"
"Urea Cycle",-0.316417379674907,2.90531115557552e-26,-0.369755893553278,-0.263078865796536,-0.0583177485425949,0.141909714864677,-0.136267370240607,0.0196318731554168,0.264280168738924,1.22602393536328e-13,0.200276295732321,0.328284041745527,"negative","negative","no"
"Valdecoxib Action Pathway",0.187519464637131,0.000110570108132183,0.0933252428325003,0.281713686441762,0.00501612532950594,0.938307726625021,-0.122478644688888,0.1325108953479,-0.157603180054538,0.0135086827303273,-0.282188140738715,-0.0330182193703611,"positive","no","no"
"Valine, Leucine, and Isoleucine Degradation",-0.104100102330896,0.000762683786319331,-0.164341717131031,-0.0438584875307608,-0.378495237059221,6.60472045941383e-19,-0.456073327036159,-0.300917147082283,-0.259692122278587,2.15320838909141e-10,-0.335025785675201,-0.184358458881973,"negative","positive","negative"
"Valproic Acid Metabolism Pathway",-0.33675748741244,3.44954600578848e-09,-0.445612416494801,-0.227902558330079,-0.196965461012049,0.0081241059862772,-0.342371630210014,-0.0515592918140835,0.109183051850509,0.184701102404112,-0.0527101410643766,0.271076244765395,"negative","no","negative"
"Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency ",-0.260250967640514,7.50457059709329e-08,-0.353129164783101,-0.167372770497926,-0.114634139474432,0.0846374134099985,-0.245037541285108,0.0157692623362431,0.133049977884619,0.0586362249135896,-0.00491991325843341,0.271019869027671,"negative","no","no"
"Warburg Effect",-0.393367266696649,1.86099840597723e-25,-0.461007653485649,-0.325726879907648,-0.24948837437226,3.95059645415763e-08,-0.336263366095349,-0.162713382649171,0.153920603343454,0.00151886676232516,0.0597693108399235,0.248071895846984,"negative","negative","negative"
"Wolman Disease",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
"Xanthine Dehydrogenase Deficiency ",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Xanthinuria Type I",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Xanthinuria Type II",-0.130841335635706,2.92634742973236e-05,-0.191515952695189,-0.0701667185762232,0.144435423375742,0.000520220830621071,0.0634991948410271,0.225371651910456,0.28689745724388,1.36208314014634e-10,0.204707987185374,0.369086927302386,"negative","negative","positive"
"Zellweger Syndrome",-0.0257011874331866,0.528309666312633,-0.105811487724279,0.0544091128579052,-0.26505616258889,1.91071379741981e-06,-0.372163915222406,-0.157948409955375,-0.261852025477759,9.48410873788671e-06,-0.3747062507031,-0.148997800252418,"no","positive","negative"
"Zoledronate Action Pathway",-0.101688764312773,0.0671024834392152,-0.210584534620688,0.00720700599514161,-0.431615372740534,4.60113050867341e-09,-0.57173754441306,-0.291493201068008,-0.334498919388994,3.70512363997637e-05,-0.489950563467366,-0.179047275310622,"no","positive","negative"
